Paul A. Howard

Founder at

Limulus Management Co. LLC

Health Technology

Finance

Consumer Services

Profile

Mr. Paul A. Howard is Founding Partner at Mediphase Venture Partners.
He is on the Board of Directors at Serenex, Inc. Mr. Howard was a Senior Vice President at Hambrecht & Quist Capital Management in Boston from 1992-1999, where he was responsible for managing the fund's biotechnology investments.
From 1983-1990, he was a Senior Technical Sales Executive for the Miles Biotechnology Division of Bayer A.G.
Mr. Howard earned an AB from Bowdoin College in 1981, an MS from the University of Massachusetts, Amherst in 1983, and an S.M.
from the Sloan School of Management at M.I.T.
in 1992.
He serves on the Board of Directors of Supplemental Health Care and Serenex.

Paul A. Howard active positions

Companies	Position	Start
Limulus Management Co. LLC Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million.	Founder	02/01/2011
Wellpartner LLC Wellpartner LLC Medical DistributorsDistribution Services Provides pharmacy distribution solutions and contract pharmacy administration services	Director/Board Member	-

All active positions of Paul A. Howard

Former positions of Paul A. Howard

Companies	Position	End
Tekla Capital Management LLC Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries.	Portfolio Manager-Equities	30/12/1998
Bayer AG /Plasma Products Business/ Bayer AG /Plasma Products Business/ Pharmaceuticals: MajorHealth Technology Provides plasma products	Corporate Officer/Principal	30/12/1989
TETRAPHASE PHARMACEUTICALS, INC.	Director/Board Member	-
Serenex, Inc. Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs	Director/Board Member	-

See the detail of Paul A. Howard's experience

Training of Paul A. Howard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul A. Howard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Serenex, Inc. Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs	Health Technology
Tetraphase Pharmaceuticals, Inc. Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics	Health Technology
Tekla Capital Management LLC Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries.	Finance
Wellpartner LLC Wellpartner LLC Medical DistributorsDistribution Services Provides pharmacy distribution solutions and contract pharmacy administration services	Distribution Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Bowdoin College Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bayer AG /Plasma Products Business/ Bayer AG /Plasma Products Business/ Pharmaceuticals: MajorHealth Technology Provides plasma products	Health Technology
University of Massachusetts University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Limulus Management Co. LLC Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million.	Finance